title: Production of pseudoinfectious yellow fever virus with a two-component genome.
abstract: Application of genetically modified, deficient-in-replication flaviviruses that are incapable of developing productive, spreading infection is a promising means of designing safe and effective vaccines. Here we describe a two-component genome yellow fever virus (YFV) replication system in which each of the genomes encodes complete sets of nonstructural proteins that form the replication complex but expresses either only capsid or prM/E instead of the entire structural polyprotein. Upon delivery to the same cell, these genomes produce together all of the viral structural proteins, and cells release a combination of virions with both types of genomes packaged into separate particles. In tissue culture, this modified YFV can be further passaged at an escalating scale by using a high multiplicity of infection (MOI). However, at a low MOI, only one of the genomes is delivered into the cells, and infection cannot spread. The replicating prM/E-encoding genome produces extracellular E protein in the form of secreted subviral particles that are known to be an effective immunogen. The presented strategy of developing viruses defective in replication might be applied to other flaviviruses, and these two-component genome viruses can be useful for diagnostic or vaccine applications, including the delivery and expression of heterologous genes. In addition, the achieved separation of the capsid-coding sequence and the cyclization signal in the YFV genome provides a new means for studying the mechanism of the flavivirus packaging process.
authors: Department of Microbiology and Immunology, University of Texas Medical Branch, 301 University Boulevard, Galveston, TX 77555-1019, USA.
authors: Alexandr V
authors: AV
authors: Shustov
authors: Peter W
authors: PW
authors: Mason
authors: Ilya
authors: I
authors: Frolov
mesh_terms: D000818:Animals; D001483:Base Sequence; D002213:Capsid / Q000378:metabolism; D036022:Capsid Proteins / Q000737:chemistry; D002460:Cell Line; D006224:Cricetinae; D016679:Genome, Viral; D049452:Green Fluorescent Proteins / Q000737:chemistry; D008969:Molecular Sequence Data; D010957:Plasmids / Q000378:metabolism; D017434:Protein Structure, Tertiary; D012313:RNA / Q000378:metabolism; D013997:Time Factors; D014773:Virology / Q000379:methods; D015005:Yellow fever virus / Q000235:genetics* / Q000378:metabolism
chemical_list: D036022:Capsid Proteins; D049452:Green Fluorescent Proteins; D012313:RNA
references: Virology. 2006 Aug 1;351(2):432-43
references: 16712897
references: Virology. 2005 Jan 20;331(2):247-59
references: 15629769
references: Vaccine. 2000 Jan 6;18(11-12):1133-9
references: 10590335
references: Virology. 2000 Mar 1;268(1):49-55
references: 10683326
references: Vaccine. 2000 Jul 15;18(27):3166-73
references: 10856796
references: J Virol. 2001 Mar;75(5):2204-12
references: 11160724
references: J Virol. 2001 May;75(9):4040-7
references: 11287553
references: Virology. 2005 Mar 30;334(1):28-40
references: 15749120
references: J Virol. 2005 Jun;79(12):7597-608
references: 15919912
references: J Virol. 2005 Dec;79(24):15107-13
references: 16306582
references: Virology. 2006 Jul 20;351(1):196-209
references: 16647099
references: J Virol. 2001 Aug;75(16):7290-304
references: 11462001
references: Vaccine. 2002 Jan 15;20(7-8):1004-18
references: 11803060
references: Vaccine. 2002 Jan 15;20(7-8):1058-67
references: 11803066
references: Cell. 2002 Mar 8;108(5):717-25
references: 11893341
references: J Virol. 2002 Jun;76(11):5480-91
references: 11991976
references: J Gen Virol. 2003 May;84(Pt 5):1261-8
references: 12692292
references: EMBO J. 2003 Jun 2;22(11):2604-13
references: 12773377
references: Int J Parasitol. 2003 May;33(5-6):567-82
references: 12782056
references: Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1951-6
references: 14769933
references: J Virol. 1990 Jun;64(6):3001-11
references: 2159558
references: Virology. 1991 Jan;180(1):294-305
references: 1845826
references: Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3253-7
references: 2014249
references: J Virol. 1991 Aug;65(8):4107-13
references: 2072446
references: Virology. 1992 Jun;188(2):714-20
references: 1585642
references: J Virol. 1993 Nov;67(11):6439-46
references: 8411346
references: Virology. 1995 Oct 1;212(2):587-94
references: 7571428
references: Arch Virol. 1996;141(3-4):743-9
references: 8645110
references: J Virol. 1996 Jul;70(7):4549-57
references: 8676481
references: J Virol. 1997 Feb;71(2):1497-505
references: 8995675
references: Virology. 1997 Jan 20;227(2):353-60
references: 9018134
references: Vaccine. 1997 Apr;15(5):547-52
references: 9160523
references: J Virol. 1997 Dec;71(12):9563-9
references: 9371620
references: Virology. 1998 Oct 10;250(1):151-63
references: 9770429
references: J Virol. 1999 Apr;73(4):3095-101
references: 10074160
references: J Infect Dis. 2004 Dec 15;190(12):2104-8
references: 15551208
references: Nat Biotechnol. 2004 Dec;22(12):1567-72
references: 15558047
references: J Virol. 2005 Jan;79(1):637-43
references: 15596860
references: J Immunol. 1999 Dec 15;163(12):6756-61
references: 10586074